Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19? | Diabetes Res Clin Pract;165: 108268, 2020 07. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?

Singh, Awadhesh Kumar; Singh, Ritu.

Singh AK; Department of Diabetes & Endocrinology, G.D Hospital & Diabetes Institute, Kolkata, India. Electronic address: drawadheshkumarsingh@gmail.com.
Singh R; Department of Diabetes & Endocrinology, G.D Hospital & Diabetes Institute, Kolkata, India.

Diabetes Res Clin Pract ; 165: 108268, 2020 07.

Article in English | MEDLINE | ID: covidwho-595993

Keywords

Anti-diabetic agents; COVID-19; Diabetes; Metformin; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Diabetes Res Clin Pract Journal subject: Endocrinology Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Diabetes Res Clin Pract Journal subject: Endocrinology Year: 2020 Document Type: Article